Search from website

GMP manufacturing

Leave your inquiry here:

Leave your inquiry here:

Accelerated Therapeutic Protein GMP Manufacturing

From discovery R&D milligrams to clinical GMP kilograms

 

Icosagen Cell Factory is a specialized European mammalian protein drug discovery, development, and manufacturing expert. By early 2024, the company will operate its own, on site, state-of-the-art GMP manufacturing plant from 50-1000L bioreactor scale. With this, and dedicated project managers, our client partners can seamlessly transition their antibody and recombinant protein drug candidates from preclinical stage into Phase I/II clinical trials.

The brand-new facility is designed and constructed for high-throughput biologics GMP manufacturing. It will be outfitted with the latest single-use equipment for the production of bulk drug substance, housing QC & QA, cell banking, seed train, upstream and downstream suites.

SEAMLESS
TRANSITION

SEAMLESS TRANSITION

From discovery to large scale production.

FAST in vivo
APPROACH

FAST in vivo APPROACH

After immunization stage, biologically active antibodies with optimal physicochemical properties can be delivered as fast as 8 to 9 weeks.

IMMUNIZATION
AGILITY

IMMUNIZATION AGILITY

Immunization of chickens with DNA, peptides, proteins or VLPs can be used to develop antibodies against hard-to-express proteins.

FLEXIBLE

FLEXIBLE

All identified sequences can be used for production of different immune molecules (bi-specifics, chimeras, antibody fragmens etc.)

COMPLEX
TARGETS

WORKS WITH COMPLEX TARGETS

Integral membrane proteins as feasible targets.
Shopping Cart